According to our (Global Info Research) latest study, the global Urine Particle Analysis System market size was valued at US$ 603 million in 2025 and is forecast to a readjusted size of US$ 814 million by 2032 with a CAGR of 4.4% during review period.
In 2025, the global production of Urine Particle Analysis Systems reached approximately 18,600 units, with an average selling price of approximately US$31,500 per unit, production capacity of approximately 22,500 units, and an average gross margin of approximately 45.0%.
Urine Particle Analysis System is an in-vitro diagnostic system designed for the automated detection, identification, classification, and quantitative analysis of formed elements in urine. Major target particles include red blood cells, white blood cells, epithelial cells, casts, crystals, bacteria, and yeast-like cells. These systems typically employ flow cytometry, digital imaging, automated microscopic imaging, or combinations of these technologies to perform urine particle analysis through automated sample handling, signal or image acquisition, and algorithm-based identification. They can operate as standalone systems or be integrated with urine chemistry analyzers to form automated urinalysis workstations, and are mainly used in hospital laboratories, independent clinical laboratories, health examination centers, and other clinical diagnostic facilities.
The global Urine Particle Analysis System market is gradually shifting from conventional manual microscopy toward automated, digital, and intelligent testing. Demand from clinical laboratories for higher sample throughput, reduced manual microscopy workload, and greater standardization of test results represents a major market driver. In terms of technology, high-throughput automated sampling, digital imaging, flow-based analysis, AI-assisted particle recognition, and integrated urine chemistry and formed-element analysis are becoming key development trends. The high-end market includes major international IVD companies such as Sysmex, Beckman Coulter, Roche, and Siemens Healthineers, while Chinese manufacturers such as Mindray and Dirui are expanding their product portfolios and competitiveness in automated urinalysis. With further adoption of clinical laboratory automation, workflow integration, and diagnostic equipment upgrades in healthcare institutions, the penetration of automated urine particle analysis systems is expected to continue increasing.
Report Scope
This report is a detailed and comprehensive analysis for global Urine Particle Analysis System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Urine Particle Analysis System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Urine Particle Analysis System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Urine Particle Analysis System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Urine Particle Analysis System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Urine Particle Analysis System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Urine Particle Analysis System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Beckman Coulter, Arkray, HUMAN Diagnostics, Roche, Siemens, Dirui Industrial, Mindray, AUTION, 77 Elektronika, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Urine Particle Analysis System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Fully Automatic
Semi-automatic
Market segment by Analysis Technology
Flow Cytometry-based
Digital Imaging-based
Microscopic Imaging-based
Hybrid Analysis-based
Market segment by Sample Throughput
Low-throughput (<60 Samples/Hour)
Medium-throughput (60–120 Samples/Hour)
High-throughput (>120 Samples/Hour)
Market segment by Application
Hospital
Clinic
Laboratory
Other
Major players covered
Sysmex Corporation
Beckman Coulter
Arkray
HUMAN Diagnostics
Roche
Siemens
Dirui Industrial
Mindray
AUTION
77 Elektronika
Bio-Rad Laboratories
Analyticon Biotechnologies
EKF Diagnostics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Urine Particle Analysis System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Urine Particle Analysis System, with price, sales quantity, revenue, and global market share of Urine Particle Analysis System from 2021 to 2026.
Chapter 3, the Urine Particle Analysis System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urine Particle Analysis System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Urine Particle Analysis System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Urine Particle Analysis System.
Chapter 14 and 15, to describe Urine Particle Analysis System sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Urine Particle Analysis System. Industry analysis & Market Report on Urine Particle Analysis System is a syndicated market report, published as Global Urine Particle Analysis System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Urine Particle Analysis System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.